Fredrik Lehmann Insider Profile
4 Followers
Fredrik Lehmann, Head of Research & Development at Oncopeptides AB, holds 32.70K shares in Oncopeptides AB (Ticker: SE:ONCO).
Fredrik Lehmann's Trading History
| ONCOOncopeptides AB | Feb 24, 2022 | Head of Research & Development | Uninformative Sell | 1.29K | kr57.88K | |||||||||||||||||||||||||||||||||||||||||||
SE:ONCO Insider Shares: 32.70K (4.34%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Fredrik Lehmann insider profile FAQ
What is the percentage of profitable transactions made by Fredrik Lehmann?
The percentage of profitable transactions made by Fredrik Lehmann is 82%.
What is the average return per transaction made by Fredrik Lehmann?
The average return per transaction made by Fredrik Lehmann is 44.90%.
What stocks does Fredrik Lehmann hold?
Fredrik Lehmann holds: SE:ONCO stocks.
What was Fredrik Lehmann’s latest transaction?
Fredrik Lehmann’s latest transaction was an Uninformative Sell of kr1.29K.
What was Fredrik Lehmann's most profitable transaction?
Fredrik Lehmann’s most profitable transaction was an Informative Buy of SE:ONCO stock on July 14, 2017. The return on the trade was 216.40%.
What is Fredrik Lehmann's role in Oncopeptides AB?
Fredrik Lehmann's role in Oncopeptides AB is Head of Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
